You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石药集团(01093.HK)料未来三年将上市新产品50余个
阿思达克 08-05 16:56
石药集团(01093.HK)副总裁孙聚民指,疫情期间,集团一方面配合政府积极抗疫,全力生产供应盐酸阿比多尔,另一方面通过线上学术会议、空中课堂等,创新学术推广形式,一定程度上化解部分影响。

他指,公司通过创新增加自己的抗压强度,保证在变化的浪潮中不断实现价值增值。

他又指,目前在研项目300余项,其中小分子创新药40余项、大分子创新药50余项,主要聚焦在肿瘤、自身免疫、精神神经、消化和代谢、心脑血管系统及抗感染六大治疗领域,同时积极对外寻找合作及收购的机会,为未来增长提供有力支撑。未来三年,集团将上市新产品50余个,其中预计市场空间超过10亿元的产品不少於15个。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account